한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제13권1호
  • /
  • Pages.42-48
  • /
  • 2009
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지

췌-십이지장절제술에 있어서 췌-공장문합방법에 따른 합병증 비교

The Complication Rate according to the Method of Pancreaticojejunostomy after Pancreaticoduodenectomy

  • 박정훈 (계명대학교 의과대학 외과학교실) ;
  • 최영일 (계명대학교 의과대학 외과학교실) ;
  • 김용훈 (계명대학교 의과대학 외과학교실) ;
  • 강구정 (계명대학교 의과대학 외과학교실) ;
  • 임태진 (계명대학교 의과대학 외과학교실)
  • Park, Jung-Hun (Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Keimyung University School of Medicine) ;
  • Choi, Young-Il (Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Keimyung University School of Medicine) ;
  • Kim, Yong-Hoon (Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Keimyung University School of Medicine) ;
  • Kang, Koo-Jeong (Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Keimyung University School of Medicine) ;
  • Lim, Tae-Jin (Division of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Keimyung University School of Medicine)
  • 발행 : 2009.03.25

⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study was designed to compare and analyze the complication rates of different anastomotic methods of pancreaticojejunostomy after performing pancreaticoduodenectomies by a single surgeon. Methods: From January 2000 to August 2007, 92 patients underwent pancreaticoduodenectomy at a single institution. According to the texture of the pancreas and pancreatic duct size (below or above 3 mm), the type of pancreaticojejunal anastomosis was selected (either duct-to-mucosa pancreaticojejunostomy or end-to-side pancreaticojejunostomy with polyethylene tube). Results: The pathologic diagnosis of the 92 patients included 81 patients with adenocarcinoma, five with chronic pancreatitis and three with GIST that developed in the duodenum. The adenocarcinomas include 33 distal CBD cancers, 18 pancreatic head cancers, 27 Ampulla of Vater cancers and 6 duodenal cancers. The pancreatic fistula rate was not significantly different between the duct-to-mucosa group and the end-to-side pancreaticojejunostomy group (nine of the 43 patients in the duct-to-mucosa group (20.9%) and six of the 46 patients in the tube insertion group (13.0%) (p=0.4). The rate of pancreatic fistula, as classified by three different consecutive periods (period I: 2000-2003; period II: 2004-2005; period III: 2006-2007), was markedly decreased and there were less complications with increasing experience (period I: 33.3%; II: 7.1%; III: 6.4%) (p=0.001). Conclusion: When performing pancreaticojejunostomy, both the duct-to-mucosa method and the tube insertion method were effective in decreasing the complication rate if the appropriate method was selected according to the texture of the pancreas and the size of pancreatic duct. The surgeon's experience and skill can affect the occurrence of pancreatic fistula after pancreaticojejunostomy. Enough experience is the most important factor to decrease the complication rate after pancreaticoduodenectomy.

키워드

참고문헌

  1. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763-779. https://doi.org/10.1097/00000658-193510000-00023
  2. Yuk GY, Lee KH, Choi DW. Clinical Analysis of 164 pancreaticoduodenectomy. Korean J Hepatobiliary Pancreat Surg 2000; 4(2):205-214.
  3. Lee JB, Ahn SI, Lee KY, et al. Risk Factors Affecting Pancreatic Fistula after Pancreaticoduodenectomy. Korean J Hepatobiliary Pancreat Surg 2007; 11(3):25-31.
  4. Jeon SH, Park KT, Jang HJ, et al. Clinical Analysis for the Postoperative Complications of Pancreaticoduodenectomy in the Recent 5 Years. Korean J Hepatobiliary Pancreat Surg 2008; 12(4):287-293.
  5. Crist DW, Cameron JL. The current status of the Whipple operation for periampullary carcinoma. Adv Surg 1992; 25:21-49.
  6. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997; 226(3):248-257; discussion 257-260.
  7. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244(1):10-15. https://doi.org/10.1097/01.sla.0000217673.04165.ea
  8. Yeo CJ, Cameron JL, Maher MM, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 1995; 222(4):580-588; discussion 588-592. https://doi.org/10.1097/00000658-199510000-00014
  9. van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 1997; 185(1):18-24. https://doi.org/10.1016/S1072-7515(01)00876-6
  10. Lee SE, Kim SW, Jang JY, Han SS, Park YH. Pancreatic Fistula after Pancreaticoduodenectomy: A Comparison between the Two Pancreaticojejunostomy Methods for Approximating the Pancreatic Parenchyma to the Jejunal Seromuscular Layer: Interrupted Vs. Continuous Stitches. Korean J Hepatobiliary Pancreat Surg 2006; 10(1):34-40.
  11. Chen HW, Lai EC, Su SY, et al. Modified technique of pancreaticojejunal anastomosis with invagination following pancreaticoduodenectomy: a cohort study. World J Surg 2008; 32(12):2695-2700. https://doi.org/10.1007/s00268-008-9760-0
  12. Kim JH, Yoo BM, Kim WH. Which method should we select for pancreatic anastomosis after pancreaticoduodenectomy? World J Surg 2009; 33(2):326-332. https://doi.org/10.1007/s00268-008-9827-y
  13. Closset J, Journe S, Mboti F, El Nakadi I, Gelin M. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy. Hepatogastroenterology 2008; 55(86-87):1818-1823.
  14. Kollmar O, Moussavian MR, Richter S, et al. Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized doubleblinded placebo-controlled trial. Eur J Surg Oncol 2008; 34(8):868-875. https://doi.org/10.1016/j.ejso.2008.01.014
  15. Zeng Q, Zhang Q, Han S, et al. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Pancreas 2008; 36(1):18-25. https://doi.org/10.1097/mpa.0b013e3181343f5d
  16. D'Andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: it is useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol 1994; 26(6):283-286.
  17. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138(1):8-13. https://doi.org/10.1016/j.surg.2005.05.001
  18. Bartoli FG, Arnone GB, Ravera G, Bachi V. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 1991; 11(5):1831-1848.
  19. Bottger TC, Junginger T. Factors influencing morbidity and mortality after pancreaticoduodenectomy: critical analysis of 221 resections. World J Surg 1999; 23(2):164-171; discussion 171-162. https://doi.org/10.1007/PL00013170
  20. Yeo CJ, Cameron JL. Improving results of pancreaticoduodenectomy for pancreatic cancer. World J Surg 1999; 23(9):907-912. https://doi.org/10.1007/s002689900598
  21. Kazanjian KK, Hines OJ, Duffy JP, et al. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg 2008;143(12):1166-1171. https://doi.org/10.1001/archsurg.143.12.1166
  22. Yeo CJ, Wang BH, Anthone GJ, Cameron JL. Surgical experience with pancreatic islet-cell tumors. Arch Surg 1993; 128(10):1143-1148. https://doi.org/10.1001/archsurg.1993.01420220063008
  23. Berberat PO, Friess H, Kleeff J, Uhl W, Buchler MW. Prevention and treatment of complications in pancreatic cancer surgery. Dig Surg 1999; 16(4):327-336. https://doi.org/10.1159/000018743
  24. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg 1995; 221(2):133-148. https://doi.org/10.1097/00000658-199502000-00003
  25. Chew DK, Attiyeh FF. Experience with the Whipple procedure (pancreaticoduodenectomy) in a university-affiliated community hospital. Am J Surg 1997; 174(3):312-315. https://doi.org/10.1016/S0002-9610(97)00110-4
  26. Roder JD, Stein HJ, Bottcher KA, et al. Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg 1999; 229(1):41-48. https://doi.org/10.1097/00000658-199901000-00005
  27. Poon RT, Fan ST. Decreasing the pancreatic leak rate after pancreaticoduodenectomy. Adv Surg 2008; 42:33-48. https://doi.org/10.1016/j.yasu.2008.03.013
  28. Adam U, Makowiec F, Riediger H, et al. Risk factors for complications after pancreatic head resection. Am J Surg 2004; 187(2):201-208. https://doi.org/10.1016/j.amjsurg.2003.11.004
  29. Choi JJ, Choi H, Shin DS, Song IS, Bae JS. Risk Factors for the Pancreatic Leakage after Pancreaticoduodenectomy. Korean J Hepatobiliary Pancreat Surg 2005; 9(4):225-232.